Combining MRI with NIHSS Thresholds to Predict Outcome in Acute Ischemic Stroke: Value for Patient Selection

REFERENCES

1. 1.↵
   Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581–87

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Hacke W,
   3. Kaste M,
   4. Bluhmki E, et al

   . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317–29

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Cocho D,
   3. Belvis R,
   4. Marti-Fabregas J, et al

   . Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 2005;64:719–20

   CrossRef
4. 4.↵
   2. Schlaug G,
   3. Benfield A,
   4. Baird AE, et al

   . The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999;53:1528–37

   CrossRef
5. 5.↵
   2. Davis SM,
   3. Donnan GA,
   4. Parsons MW, et al

   . Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Mishra NK,
   3. Albers GW,
   4. Davis SM, et al

   . Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 2010;41:e25–33

   Abstract/FREE Full Text
7. 7.↵
   2. Hacke W,
   3. Furlan AJ,
   4. Al-Rawi Y, et al

   . Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141–50

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Kidwell CS,
   3. Jahan R,
   4. Gornbein J, et al

   . A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368:914–23

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Sanak D,
   3. Nosal V,
   4. Horak D, et al

   . Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis. Neuroradiology 2006;48:632–39

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Yoo AJ,
    3. Verduzco LA,
    4. Schaefer PW, et al

    . MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009;40:2046–54

    Abstract/FREE Full Text
11. 11.↵
    2. Sato S,
    3. Toyoda K,
    4. Uehara T, et al

    . Baseline NIH Stroke Scale score predicting outcome in anterior and posterior circulation strokes. Neurology 2008;70:2371–77

    CrossRef
12. 12.↵
    2. Yoo AJ,
    3. Barak ER,
    4. Copen WA, et al

    . Combining acute diffusion-weighted imaging and mean transmit time lesion volumes with National Institutes of Health Stroke Scale score improves the prediction of acute stroke outcome. Stroke 2010;41:1728–35

    Abstract/FREE Full Text
13. 13.↵
    2. Wu O,
    3. Østergaard L,
    4. Weisskoff RM, et al

    . Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003;50:164–74

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Furlan AJ,
    3. Eyding D,
    4. Albers GW, et al

    . Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227–31

    Abstract/FREE Full Text
15. 15.↵
    2. Hacke W,
    3. Albers G,
    4. Al-Rawi Y, et al

    . The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73

    Abstract/FREE Full Text
16. 16.↵
    2. Parsons MW,
    3. Christensen S,
    4. McElduff P, et al

    . Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010;30:1214–25

    CrossRefPubMed
17. 17.↵
    2. DeGraba TJ,
    3. Hallenbeck JM,
    4. Pettigrew KD, et al

    . Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke 1999;30:1208–12

    Abstract/FREE Full Text
18. 18.↵
    2. Galldiks N,
    3. Zaro-Weber O,
    4. Dohmen C, et al

    . Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience. Cerebrovasc Dis 2010;30:514–18

    CrossRefPubMed
19. 19.↵
    2. Phan TG,
    3. Chen J,
    4. Donnan G, et al

    . Development of a new tool to correlate stroke outcome with infarct topography: a proof-of-concept study. Neuroimage 2010;49:127–33

    CrossRefPubMed
20. 20.↵
    2. Sims JR,
    3. Gharai LR,
    4. Schaefer PW, et al

    . ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 2009;72:2104–10

    CrossRef